Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

Avoiding smoking, stress, obesity, and poor diet may help reduce hair loss in young Egyptian males.

Combining microneedling with light therapy increased hair density by 26% in men.

The document explains how hair loss in men and women, known as Androgenetic alopecia, is categorized using the Hamilton-Norwood system for men and the Ludwig grade system for women.

Using a gel called Diclofenac can potentially cause hair to grow back in bald spots in older men.

The research found that certain genes are linked to male pattern baldness, but these same genes do not affect female pattern hair loss.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Middle-aged women in Iran are most affected by primary cicatricial alopecia, especially discoid lupus erythematous.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Growth factors greatly affect hair loss, with different levels seen in men, women, younger patients, and at the start of the condition.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

The document concludes that early and accurate diagnosis of hair loss on the top of the scalp in Black men is important to distinguish CCCA from other types of hair loss.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Rosemary oil may effectively treat hair loss with fewer side effects, but more research is needed.

Smoking and alcohol worsen hair transplant results.